Melanoma
Latest News
A cost-effective de-escalation strategy in advanced melanoma
While the use of immunotherapies over the past decade has improved the prognosis for patients with advanced melanoma, these drugs come with a...
Latest News
Reminder that COVID-19 and cancer can be a deadly combo
“This analysis provides additional empirical evidence on the magnitude of risk to patients with cancer whose immune systems are often weakened...
Diminutio
Cancer as a full contact sport
The complexity of cancer care has long necessitated a team approach to planning cancer treatment.
From the Journals
Despite benefits, extended-interval pembro uptake remains low
It’s possible that low uptake could stem from clinicians’ doubts about switching to an extended-interval dose, given that the FDA’s approval was...
From the Journals
In stage IIIA melanoma, nodal tumor size could guide decision-making
Sentinel node tumors 3 mm or larger should be considered for adjuvant therapy, while smaller sizes could be treated similarly to AJCC IB.
Conference Coverage
A farewell to arms? Drug approvals based on single-arm trials can be flawed
Objective responses, not time-dependent survival outcomes, should be endpoints for single-arm trials, with results only used for conditional...
Conference Coverage
Time to cancer diagnoses in U.S. averages 5 months
Diagnosis time varied significantly across tumor types, as well as within the same tumor type.
From the Journals
BRAF/MEK combo shows long-term efficacy in melanoma
Despite positive results, immunotherapy likely remains the best choice for first-line treatment of BRAFV600 mutated advanced melanoma.
Conference Coverage
Not just what, but when: Neoadjuvant pembrolizumab in melanoma
Neoadjuvant pembrolizumab followed by pembrolizumab improves event-free survival in resectable melanoma.
Conference Coverage
Novel cell therapy beats immunotherapy in melanoma
The treatment of patients with melanoma who do not respond to or progress after receiving immunotherapy is “challenging and represents an unmet...
Conference Coverage
‘Smoking gun–level’ evidence found linking air pollution with lung cancer
The finding could lead to strategies for preventing lung cancer in nonsmokers exposed to high levels of foul air.